Coronavirus News: COVID-19 increases urgency for Tablo Hemodialysis Systems "We think 30% of ICU patients are developing acute kidney injury," said Dr. David Goldfarb, Chief of Nephrology at New York Harbor VA Medical Center. Dr. Goldfarb said he could not predict this kind of system failure that occurred with patients infected with the [...]
New Formulation of Tiopronin Receives FDA Approval for Treatment of Cystinuria Officials with the FDA have approved a new enteric-coated formulation of tiopronin (Thiola EC, Retrophin) 100 mg and 300 mg tablets, for the treatment of cystinuria, a rare inherited disorder that causes a buildup of cystine levels in the urine, resulting in [...]
α-Lipoic Acid (ALA) Improves Cystine Solubility in Cystinuria: Report of 2 Cases A recent study revealed efficacy of nutritional supplement α-lipoic acid (ALA) treatment in preventing kidney stones in a mouse model of cystinuria. Here, we report 2 pediatric patients (6 and 15 years old) with cystinuria who received regular doses of ALA [...]
Retrophin Announces FDA Approval of THIOLA® EC (tiopronin) 100mg and 300mg Tablets Retrophin, Inc. (NASDAQ: RTRX) today announced that the U.S. Food and Drug Administration (FDA) has approved 100 mg and 300 mg tablets of THIOLA® EC (tiopronin), a new enteric-coated formulation of THIOLA® (tiopronin), to be used for the treatment of cystinuria, a [...]